new glp-1 agonist Machine learning designs GCGR/GLP-1R dual agonists with enhanced biological potency Could GLP-1 Receptor Agonists Help

Its predominant action is on the postprandial glucose levels, with extraglycemic effects on fat metabolism and endovascular function

National Taiwan University researchers highlight the benefits of GLP-1 receptor agonists (GLP-1 RAs) in reducing mortality and severe cardiovascular and renal outcomes for diabetic patients with acute kidney disease (AKD)

Visit Us!

The development of dual GIPRGLP1R coagonists that bind to either one or the other receptor (sequence-mixed dual agonists) has emerged as an innovative therapeutic strategy for obesity and type 2 diabetes

Explore the pros and cons of GLP-1 medications for managing type 2 diabetes and weight loss.

Purpose of Review This review explores the role of GLP-1 receptor agonists (GLP-1 RAs) in addressing metabolic dysfunction and neurodegeneration in Parkinsons disease (PD), focusing on body weight regulation and neuroprotection